These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
599 related articles for article (PubMed ID: 25567227)
1. Antimicrobial heteroresistance: an emerging field in need of clarity. El-Halfawy OM; Valvano MA Clin Microbiol Rev; 2015 Jan; 28(1):191-207. PubMed ID: 25567227 [TBL] [Abstract][Full Text] [Related]
3. Mechanisms and clinical relevance of bacterial heteroresistance. Andersson DI; Nicoloff H; Hjort K Nat Rev Microbiol; 2019 Aug; 17(8):479-496. PubMed ID: 31235888 [TBL] [Abstract][Full Text] [Related]
4. What's new on the antimicrobial horizon? Song JH Int J Antimicrob Agents; 2008 Dec; 32 Suppl 4():S207-13. PubMed ID: 19134521 [TBL] [Abstract][Full Text] [Related]
5. Why is antibiotic resistance a deadly emerging disease? Courvalin P Clin Microbiol Infect; 2016 May; 22(5):405-7. PubMed ID: 26806259 [TBL] [Abstract][Full Text] [Related]
6. Antibiotic resistance. Frieri M; Kumar K; Boutin A J Infect Public Health; 2017; 10(4):369-378. PubMed ID: 27616769 [TBL] [Abstract][Full Text] [Related]
7. The high prevalence of antibiotic heteroresistance in pathogenic bacteria is mainly caused by gene amplification. Nicoloff H; Hjort K; Levin BR; Andersson DI Nat Microbiol; 2019 Mar; 4(3):504-514. PubMed ID: 30742072 [TBL] [Abstract][Full Text] [Related]
8. [Glycopeptide heteroresistance and tolerance in hospital grampositive isolates: "invisible" phenomena to the clinician with clinical implications?]. Aguilar L; Giménez MJ; Barberán J Rev Esp Quimioter; 2009 Dec; 22(4):173-9. PubMed ID: 20082037 [TBL] [Abstract][Full Text] [Related]
9. Novel antibiotics: are we still in the pre-post-antibiotic era? Draenert R; Seybold U; Grützner E; Bogner JR Infection; 2015 Apr; 43(2):145-51. PubMed ID: 25701222 [TBL] [Abstract][Full Text] [Related]
10. Comparative evaluation of the VITEK 2, disk diffusion, etest, broth microdilution, and agar dilution susceptibility testing methods for colistin in clinical isolates, including heteroresistant Enterobacter cloacae and Acinetobacter baumannii strains. Lo-Ten-Foe JR; de Smet AM; Diederen BM; Kluytmans JA; van Keulen PH Antimicrob Agents Chemother; 2007 Oct; 51(10):3726-30. PubMed ID: 17646414 [TBL] [Abstract][Full Text] [Related]
11. Antibiotic heteroresistance in ESKAPE pathogens, from bench to bedside. Roch M; Sierra R; Andrey DO Clin Microbiol Infect; 2023 Mar; 29(3):320-325. PubMed ID: 36270588 [TBL] [Abstract][Full Text] [Related]
12. How to fight antimicrobial resistance. Foucault C; Brouqui P FEMS Immunol Med Microbiol; 2007 Mar; 49(2):173-83. PubMed ID: 17181560 [TBL] [Abstract][Full Text] [Related]
13. Discerning the role of polymicrobial biofilms in the ascent, prevalence, and extent of heteroresistance in clinical practice. Lopes SP; Jorge P; Sousa AM; Pereira MO Crit Rev Microbiol; 2021 Mar; 47(2):162-191. PubMed ID: 33527850 [TBL] [Abstract][Full Text] [Related]
14. Bacterial Heterogeneity and Antibiotic Survival: Understanding and Combatting Persistence and Heteroresistance. Dewachter L; Fauvart M; Michiels J Mol Cell; 2019 Oct; 76(2):255-267. PubMed ID: 31626749 [TBL] [Abstract][Full Text] [Related]
15. Antimicrobial management of complicated skin and skin structure infections in the era of emerging resistance. Lee SY; Kuti JL; Nicolau DP Surg Infect (Larchmt); 2005; 6(3):283-95. PubMed ID: 16201938 [TBL] [Abstract][Full Text] [Related]
18. The challenge of antibiotic resistant bacterial pathogens: the medical need, the market and prospects for new antimicrobial agents. Payne D; Tomasz A Curr Opin Microbiol; 2004 Oct; 7(5):435-8. PubMed ID: 15451496 [No Abstract] [Full Text] [Related]
19. Persisters and beyond: mechanisms of phenotypic drug resistance and drug tolerance in bacteria. Kester JC; Fortune SM Crit Rev Biochem Mol Biol; 2014; 49(2):91-101. PubMed ID: 24328927 [TBL] [Abstract][Full Text] [Related]